Select Bibliography

Filter by any of these (after searching):

N05C7

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 2 items

Long-acting methylphenidate for cancer-related fatigue: NCCTG trial N05C7

Barton, D. L. , Moraska, A. R. , Sood, A. , Sloan, J. A. , Suh, J. J. ... - ASCO - J. Clin. Oncol. - 2010

Abstract - Primary - Primary - Symptom Inter - N05C7

Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial

Moraska, A. R. , Sood, A. , Dakhil, S. R. , Sloan, J. A. , Barton, D. ... - - J. Clin. Oncol. - 2010

Manuscript - Primary - Primary - Symptom Inter - N05C7